Tariq Dayah, MD, MPH
Basic profileThe University of Texas MD Anderson Cancer Center
Tariq Dayah is a Cardiology physician affiliated with The University of Texas MD Anderson Cancer Center. OpenAlex indexes 16 publications with 244 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
18400 Katy Fwy Ste 600
Houston, TX 770941296
Telephone
713-464-2928Provider last certified this registry record 19 Sept 2024.
Industry payments
32 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Edwards Lifesciences CorporationProgram year202513 payments
- Amgen Inc.Program year202515 payments
- Merck Sharp & Dohme LLCProgram year20259 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
85.6%Beta blocker15.8%Metoprolol Succinate36%Metoprolol Tartrate27%Carvedilol24%Nebivolol Hcl7%Bisoprolol Fumarate3%Atenolol3%Part D<11 patientsAdenosine Receptor Agonist14%Regadenoson100%Part B, office-administered≥205 patients+ 18 more classes in this area
Blood & clotting
12%Factor Xa inhibitor6.7%Eliquis81%Xarelto19%Part D≥92 patientsP2Y12 inhibitor4.3%Clopidogrel89%Brilinta11%Part D≥82 patients+ 1 more class in this area
Metabolism & gastrointestinal
1.7%SGLT2 inhibitor0.6%Jardiance68%Farxiga32%Part D<11 patientsProton pump inhibitor0.6%Pantoprazole Sodium68%Omeprazole32%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Trigger related outcomes of takotsubo syndrome in a cancer population
Frontiers in Cardiovascular Medicine
2022 - D-9 | Additional Value of Instant Wave Free Ratio (iFR) on Standard Quantitative Coronary Angiography (QCA) in Cancer Patients
Journal of the Society for Cardiovascular Angiography & Interventions
2022 - Refractory radiation-induced coronary artery disease: mapping the path and guiding treatment with optical coherence tomography
International journal of cardiac imaging
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Hagop Kantarjian, MD
The University of Texas MD Anderson Cancer Center
Gabriel Hortobagyi, MD
The University of Texas MD Anderson Cancer Center
Jaffer Ajani, MD
The University of Texas MD Anderson Cancer Center
Funda Meric-Bernstam, MD
The University of Texas MD Anderson Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”